Biosystems International Raises $2.7M | GenomeWeb

By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – Parisian protein biomarker firm Biosystems International said today it has closed on a funding round raising €2.1 million ($2.7 million).

The funds will be used to complete development of the company's lung cancer diagnostic test and to bring it to market in 2011, BSI said in a statement, adding that the round was raised primarily by its principle investors.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PLOS this week: nasal microbial communities in asthma patients; sequencing-based way to detect, track schistosomiasis; and more.

The New York Times speaks with Vanderbilt's John Anthony Capra about Neanderthal genes in modern humans.

A draft guidance from the FDA suggests the agency wants to more tightly control gene-edited animals, according to Technology Review.

Researchers were among this weekend's protesters bemoaning the new US administration, Vox reports.